Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer

Dr. Tiffany Traina, a medical oncologist from Memorial Sloan Kettering Cancer Center, dives deep into the management of metastatic BRCA-negative, triple-negative breast cancer. She discusses personalized treatment strategies, emphasizing chemotherapy combined with pembrolizumab for PD-1 positive patients. The conversation also highlights the importance of biopsies and emerging therapies like enzalutamide and antibody-drug conjugates. Additionally, she addresses the complexities of treating elderly patients and navigating toxicity, all while exploring the latest advancements in treatment options.